Corpus Intelligence IC Memo — BERGER HOSPITAL 2026-04-26 17:42 UTC
IC Memo — BERGER HOSPITAL
Investment Committee Memorandum | OH | 83 beds | Grade C | EBITDA uplift $8.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BERGER HOSPITAL

CCN 360170 | PICKAWAY, OH | 83 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BERGER HOSPITAL is a 83-bed suburban community hospital in PICKAWAY, OH with $111.6M in net patient revenue and a 14.4% operating margin. The hospital serves a payer mix of 24.3% Medicare, 5.9% Medicaid, and 69.8% commercial.

Thesis: Turnaround. Our ML models identify $8.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 14.4% to 21.8% (+736bps).

Net Revenue HCRIS$111.6M
Current EBITDA COMPUTED$16.1M
Operating Margin COMPUTED14.4%
Occupancy HCRIS33.6%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS35.4%
Distress Probability ML52.6%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
95
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 14.4% places it above the state median. Among 95 size-comparable peers (42-166 beds), the median margin is 2.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (42-166), prioritizing same-state peers. 95 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BERGER HOSPITAL (Target)OH83$111.6M14.4%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
WEST CHESTER HOSPITAL LLCOH163$318.7M-12.3%
BLANCHARD VALLEY REG. HEALTH COH152$310.1M22.8%
SOIN MEDICAL CENTEROH120$256.3M-1.3%
LIMA MEMORIAL HOSPITALOH110$253.5M6.4%
UH AHUJA MEDICAL CENTEROH153$249.4M3.3%
TRINITY HOSPITAL HOLDING COMPAOH162$244.3M-13.3%
FIRELANDS REGIONAL MEDICAL CENOH146$238.4M-13.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$71K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.4M
Clean Claim Rate
$71K
Total EBITDA Uplift$8.2M
Current EBITDA$16.1M
+ RCM Uplift+$8.2M
Pro Forma EBITDA$24.3M
Current Margin14.4%
Pro Forma Margin21.8%
WC Released (1x)$4.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$24.8M$188.3M7.61x50.0%
Base (11x exit)10.0x11.0x$24.8M$215.2M8.69x54.1%
Bull Case9.0x11.0x$22.3M$250.3M11.23x62.2%
Bull (12x exit)9.0x12.0x$22.3M$279.7M12.55x65.9%
Bear Case11.0x10.0x$27.2M$139.2M5.11x38.6%
Bear (11x exit)11.0x11.0x$27.2M$162.0M5.95x42.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 33.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 95 hospitals with 42-166 beds
  • Same-state prioritization (n=96)
  • Comp margins: P25=-13.4% / P50=2.7% / P75=9.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.